News and Announcements
Venture Investing in a Recession
- Published November 03, 2022 7:44AM UTC
- Publisher Maan Perez
- Categories Venture Investor Interviews
Public markets are correcting, VC money is drying up and investors are as prudent as ever. Surrounded by these signs of a depressed market, investors in the process of deploying capital may need to change their methods of analysis and deal structure in order to ensure proper entry prices.
Watch this panel session as seasoned investors discuss the best course of action for raising capital in a recession.
Panelists:
Jeb J. A. – Founder at Clearglass Capital Partners
Jenny Morel – Founder & Managing Director at Morgo
Rod Bristow – CEO at Investible
Karen Chan – Portfolio Manager at Perennial Partners
Looking for new investment opportunities? Click here to browse hundreds of companies, connect with their CEO and create your personalised deal flow.
Your AI Driven matchmaking platform
With a 14-year track record, a network of 32,000+ investors, and a capital raising platform, Wholesale investor is a leading investment platform for start-ups, scale-ups, emerging growth companies, and small caps.
Venture Investor Interviews
From Algae Pioneers to a Natural Revolution: The Second Act of WRS Bioproducts
As the US FDA prepares to phase out synthetic food colors by the end of 2026, WRS Bioproducts is stepping in to solve a looming supply crisis. Led by industry pioneer Harry Rosen, the company is leveraging 40 years of industrial algae farming expertise to scale production of natural, superior-quality beta-carotene, positioning itself as a vital supplier in the rapidly shifting global market for natural ingredients.
Dying for a Cure: Why Astraea is Stress-Testing the Future of Space Medicine
Astraea Technologies is solving a critical “blind spot” in the $1.5T space economy. Co-founders Brooke Mills and Gordon Carroll discuss their $5M seed raise, the HIRO-LAB platform, and their upcoming 2028 mission to the Moon to validate life-saving medicine in extreme environments.
Beyond the Drip: Elemental IV’s Infrastructure Play for a Fragile Supply Chain
In the high-stakes world of life sciences, we often hunt for the next “miracle molecule” or gene-editing breakthrough. But Storme Paes, Founder and Commercial Director of Elemental IV, found her mission in something far more fundamental, yet dangerously overlooked: a simple bag of saltwater. The “Meeting Room” Revelation The genesis of Elemental IV didn’t occur […]
Backed By Leading Investment Groups and Family Offices
